Select Committee on Health Minutes of Evidence


Examination of Witnesses (Questions 120-139)

THURSDAY 3 APRIL 2003

MS SUE SHARPE, MS LIZ COLLING, MR JOHN D'ARCY, MR JOHN EVANS, MR JONATHAN MAY AND MR MATTHEW JOHNSON

  120. The OFT report suggests that they are very well located.
  (Mr Evans) No, 90% of people feel that their pharmacies are in locations that they can get to; 10% say they cannot; but the location of a pharmacy, opening hours and accessibility when open is the issue. We are saying, let the market choose a level first of all; then let the PCT subsidise areas where it needs pharmacies. That is what we are saying.

Dr Naysmith

  121. Mr D'Arcy almost argued that the proposals are incompatible with the Government's plans for changing and improving pharmacies. Is that a fair summary?
  (Mr D'Arcy) Yes.

  122. You want to stay as you are now, basically.
  (Mr D'Arcy) No, we do not want to stay as we are, we want to build on what we have got. We are saying that we have a system that does work. Where there are deficiencies, let us work within the existing system to plug those gaps and work on those deficiencies.

  123. But you think the proposals are basically incompatible with that.
  (Mr D'Arcy) Yes.

  124. Is that what Liz Colling and Sue Sharpe think?
  (Ms Colling) I think so. Increasingly, pharmacists are becoming part of the wider healthcare agenda and engaging in provision of primary care health rather than retailers. We all want to move the profession along that route, and that would address some of the concerns Mr Evans has about pharmacies leaving the profession. They are a valuable resource; they want to be healthcare professionals—but we also need to preserve the diversity of the areas which they can service and the accessibility and relationships they have with their local communities. The regulations are not perfect by any stretch of the imagination, but they do however allow some new openings. We have opened new pharmacies, but we can build on them and we can use the PCTs and work with them to identify real health needs; and then find solutions to local issues.
  (Ms Sharpe) I agree entirely. In essence, community pharmacy is an NHS primary care service, closely allied to primary care medical services. It must make sense for community pharmacy services to be planned.

  125. Mr Evans, you obviously disagree profoundly with what has just been said by all three community pharmacy organisations.
  (Mr Evans) We are also a community pharmacy organisation as well. We have 81 community pharmacies working in there, so we offer a service to our customers too. It is just a bit more to one side. We think PCTs should control where pharmacies are needed, but what we are asking you boys—give us the chance to look after our 11 million customers a week to have pharmacies. That is all we are after: that is what they want and that is what we are after. We will do that for PCTs. Then let the PCTs identify where that is lacking and—

  126. But that is not a free market, is it?
  (Mr Evans) Exactly. We are not after a free market; we are after deregulation. Let the PCTs choose where the services are needed. We are not after a free market.

  127. No, but the PCTs choosing is a form of regulation. It is deregulation, but if the PCTs do that, then it is a form of regulation. They might say to you, "we are going to have pharmacy here, and we do not think you should have one there". They do not have that power at the moment, but they might do if things get developed along the suggested lines.

Julia Drown

  128. Is there not a problem with this in that of course you recognise customers want pharmacies everywhere and would like a pharmacy on every single street corner so that wherever you happen to be you can pop in with a prescription: but the problem is that this is not something where the consumer just pays for the product; we have a lot of taxpayers' money going in to support pharmacy services. As I understand it, the argument of the supermarkets and the OFT is that you let the market decide, which would naturally move the market to a fairly stable level where profits are reasonable for the supermarkets, and they are where the consumers want them; and there will be some gaps, where a subsidy scheme would be put in. That would be fine if there was not any taxpayer subsidy going in to the mainstream, the market bit. As long as taxpayers' money is going in to the mainstream market bit, we have to have some sort of regulation. Would not any economist say that if you are going to have to regulate a part of the market, you want the regulator to have all the economic power possible to get the best service for everyone across the board? You do not want to have to create a whole new extra subsidy and only be able to operate within the bit of the market that is unviable—once the market had settled itself on a commercial basis. Is that not a problem with this?
  (Mr May) Our view is—and the Social Exclusion Unit has come up with this, for example—that the existing system means that a number of people are not served well.

  129. Everybody is accepting that the system could be improved; that is across the board.
  (Mr May) Secondly, our view is that the control of entry regulations actually stifle the provision of services. They stop new people coming in offering new services.

  130. There is some agreement to that.

  (Ms Sharpe) We want to change and develop them, yes.

  (Mr May) In doing so, they cost both the taxpayer and businesses money in certain respects, and we also think there are consumer savings. We think that if you let the market essentially let people come in, you will then have provision. We also think that some of that new provision should help to deal with some of the problems that currently exist. What the PCTs and the health focus should be is looking at those areas where there is not adequate provision, and using their powers and subsidies for a targeted scheme for example, or using the way they remunerate pharmacies—and this is very important—what service are you getting from your pharmacy—to tackle those issues. We think that would be a better use of public money and everyone's time and effort.

  131. Are you not forgetting the fact that a lot of the taxpayers' money is going in to the bit that the market is settling on its own? What about the economics argument that if you are going to have to regulate the market, you want as much buying power as possible?
  (Mr May) But you would have plenty of buying power because you would be remunerating the pharmacist as you choose through the global sum, and you can change the way you do that and put a different focus on different services.

  132. So you would have to change that if you were changing the market as well. Do others agree with that?
  (Ms Colling) I am not sure I fully grasp the issue, to be honest.

  133. The point I am getting at is that it would be fine if the supermarkets were going to open many more pharmacies if that was not requiring use of taxpayers' money. The fact that you are using taxpayers' money means that given we have to have some sort of regulator dealing with the bits that—if you were that regulator you would rather have the power over all of the money.
  (Ms Colling) Absolutely.

  134. That is some regulation seen across everywhere, rather than just having what one is left over with to deal with the bits that are unviable.

  (Ms Sharpe) I think under the proposed new scheme, everybody would be providing a NHS community pharmacy service, and whether in a supermarket or wherever would expect to get their funding for the service they are providing. That is where there is an incompatibility between this idea that you do not plan and you do not ensure that you are getting the best value in terms of location and quality of service. It does not merely come through the planned regulator service.

  135. You picked up earlier some issues that the OFT is raising, that people who use pharmacies are proportionately more amongst the elderly and people with disabilities, and that is whether they are supermarkets or community pharmacies. The OFT has argued that those groups would be disproportionately affected by deregulation, and I wonder if you would agree with that.
  (Ms Sharpe) It is interesting, if you look at parts of the OFT's own study, that the over-sixties, and people who are most likely to use pharmacies for their OTC purchases and toiletries purchases—we know in answer to a parliamentary question that was answered by the Minister responsible for pharmacy very recently, that 56% of all prescriptions are for people over sixty. It seems to me to be self-evident that these are the high users of the local community pharmacy services, and therefore by definition these people with local pharmacies are threatened and will be the people to be affected.

  136. Can we move on to the issues that we have not touched on, for example social functions that pharmacies provide, things like distribution of emergency contraception, controlled Methadone distribution and so on, which are particularly important in deprived areas? Did the OFT look at that at all?
  (Mr May) No, we did not look at that. I come back to the point that you can ensure that pharmacies provide these things by making sure that when you are paying them from the global sum, you say, "these are the things we expect you to provide as a minimum" and you can force standards through that. Then you can encourage people to provide more. We saw that as very much a health policy issue. It is not really to do with the control of entry system; it does not affect that at all.

  137. It does not affect it, except if there was deregulation you are hinting strongly that the whole of the remuneration of pharmacies would have to be looked at alongside it.
  (Mr May) Only to the extent, if more people came in and the global sum remained fixed.

  138. Is not the whole reason you want to deregulate it so that more people come in?
  (Mr May) Yes, to provide an alternative.

  139. So you are suggesting that deregulation will lead to more people coming in, and therefore you would need to look at the whole way the pharmacy—
  (Mr May) I think it would be sensible to do so, and that is my understanding of what Government intends to do. That is essentially what the response to our report says. It makes sense.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2003
Prepared 17 June 2003